Patent · US Active

Drug monitoring assay

US8329872B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Patrick Albientz · Molsheim, FR
Jean-Michel Grenet · Rixheim, FR
Rainer Hillenbrand · Königsbrunn, DE
Francois Legay · Rixheim, FR
Peter Marbach · Therwil, CH
Severine Marrony · Eschentzwiller, FR
Judith Schaefer · Liestal, CH

Key dates

Filing date	Nov 7, 2011
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Nov 7, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/94
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for obtaining at least one binding agent which binds a pharmaceutically active form of the compound with a higher specificity than a pharmaceutically inactive form of the compound is described by using special derivatives of said parent compound. The invention also pertains to the respectively created binding agents and derivatives. Furthermore, drug monitoring assays using said binding agents for monitoring pharmaceutically active forms of said parent compound are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.